Skip to main content
editor@ajptr.com
9409046853
e-ISSN: 2249-3387
American Journal of PharmTech Research

American Journal of PharmTech Research

Keyword

Ornidazole

Explore 4 research publications tagged with this keyword

4Publications
14Authors
4Years

Publications Tagged with "Ornidazole"

4 publications found

2026

1 publication

FORMULATION, OPTIMIZATION AND CHARACTERIZATION OF ORNIDAZOLE NANOSTRUCTURED LIPID CARRIER GEL FOR TOPICAL DELIVERY

Dr. P. Ashok Kumar et al.
11/2/2026
pp. 191-209

The study aimed to formulate, optimize and characterize ornidazole NLCs using glyceryl monostearate (GMS), oleic acid and Tween 80 and to incorporate the optimized dispersion into a topical gel. NLCs were prepared by hot homogenization followed by ultrasonication. A three-factor, three-level Box–Behnken design comprising 17 runs was used to investigate GMS concentration, Tween 80 concentration and homogenization time. Particle size, polydispersity index (PDI), zeta potential, entrapment efficiency, drug content and in vitro drug release were evaluated. FTIR and SEM were used for physicochemical and morphological characterization. The NLC dispersion was incorporated into a Carbopol 934-based gel and evaluated for pH, spreadability, viscosity and stability. The optimized formulation (F13) had a particle size of 222.8 nm, PDI 0.289, zeta potential −26.7 mV, entrapment efficiency 83.6% and drug content 91.0%. The optimized formulation showed sustained drug release, with 82.3% cumulative drug release reported at 12 h in the response-optimization section. The optimized gel showed pH 5.73 ± 0.03, spreadability 6.28 ± 0.21 g·cm/s and viscosity 5080 ± 78 cP. FTIR analysis showed retention of characteristic ornidazole peaks without major drug–excipient interaction. The optimized formulation remained physically stable during the reported 60-day study. The study demonstrates the feasibility of developing an ornidazole-loaded NLC topical gel using a Box–Behnken design. The optimized formulation exhibited nanoscale particle size, acceptable PDI, measurable negative zeta potential, good entrapment and sustained drug release, supporting further investigation as a topical delivery system.

2021

1 publication

Development and Validation of RP-HPLC Method for estimation of Ornidazole in Ornidazole injection 5mg/mL

B.Sucharitha and V. Anuradha
4/1/2021
pp. 1-10

A new, simple, rapid, selective, precise and accurate isocratic reverse phase high performance liquid Chromatography assay method has been developed for estimation of Ornidazole in injection formulations. The separation was achieved by using column Inertsil ODS-3V (150×4.6 mm, 5µ), in mobile phase consisted of acetonitrile and pH 3.0 phosphate buffer, adjusted to pH 3.0 with the help of dilute orthophosphoric acid in the ratio of (10:90, v/v). The flow rate was 2.0 mL/min-1 and the separated Ornidazole was detected using UV detector at the wavelength of 300 nm. Column temperature 25°C and sample temperature ambient and injection volume 20µL. The retention time of Ornidazole, was noted to be 12.05 min respectively. The method was validated as per ICH guidelines. The proposed method was found to be accurate, reproducible, and consistent.

2016

1 publication

Method Development and Validation for Simultaneous Estimation of Ofloxacin and Ornidazole In Bulk and Pharmaceutical Dosage forms

Challa Sudheer et al.
4/1/2016
pp. 1-11

A simple, rapid, sensitive reverse-phase high-performance liquid chromatography method was developed and validated for simultaneous estimation of ofloxacin and ornidazole, at single wavelength of 343nm.chromotographic separation was performed on an enable aligent zorabax(thermo) column(250nmx4.6mm ID particle size 5 um) and a  mobile phase consisting of acetonitrile and buffer (600:4300v/v) at a flow rate of 1.0ml/min. the calibration curve was linear(r2≥0.0999) over the concentration range. 400-1200μg/mL of ofloxacin and 1000-3000μg/mL of ornidazole. the limit of detection 0.00246µg/ml  for ofloxacin  0.00508µg/ml for ornidazole and no interference was found by the excipients in the synthetic mixture. The proposed methods were validated for international conference on harmonization guideline for linearity, accuracy, precision, and robustness for estimation of ofloxacin and ornidazole in bulk and synthetic mixture, and The results were found to be satisfactory

2012

1 publication

Development and Validation of RP-HPLC Method for Simultaneous Determination of Ofloxacin and Ornidazole In Infusion

Pankaj B. Miniyar et al.
10/1/2012
pp. 382-390

A simple reverse phase liquid chromatographic method has been developed and subsequently validated for simultaneous determination of Ofloxacin and Ornidazole in infusion dosage form. The separation was carried out using a mobile phase containing methanol and buffer (equal proportion of 0.01M orthophosphoric acid and 0.01M sodium phosphate monobasic dihydrate) with pH 4.00 adjusted by 20% of triethylamine in the ratio of 60:40 v/v. The column used was HiQ Sil C18 (150 mm x 4.6 mm i.d, 5 µ) with flow rate of 1 mL / min using UV detection at 300 nm. The described method was linear over a concentration range of 1.25-10 µg/mL (r2>0.9991) for Ofloxacin and 3.12-25 µg/mL (r2>0.9992) for Ornidazole. Separation was achieved within 5 min. The mean % recovery was found to be 99.94% for Ofloxacin and 100.27 % for Ornidazole. The limit of detection (LOD) for Ofloxacin and Ornidazole were found to be 0.146 and 0.25 µg/mL respectively. Whereas the limit of quantification (LOQ) for Ofloxacin and Ornidazole was 0.44 and 0.77 µg/mL respectively. The results of the study showed that the proposed RP-HPLC method is simple, rapid, precise, accurate and cost effective which is useful for the routine determination of Ofloxacin and Ornidazole in bulk drug and in its infusion.

Keyword Statistics
Total Publications:4
Years Active:4
Latest Publication:2026
Contributing Authors:14
Whatsapp